Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIR2501 for Paclitaxel-Induced Peripheral Neuropathy
NCT07765446Phase 2Recruiting
- Sponsor
- Sironax
- Start
- Aug 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
A Phase 2 trial of SIR2501 in chemotherapy-induced peripheral neuropathy (CIPN), sponsored by Sironax. Started Aug 2026; status: recruiting.
02
Drugs
SIR2501
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on NCT07765446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07765446.